doi: 10.3389/fphar.2022.978421 181 ZhouY.ZhaoH.WangT.ZhaoX.WangJ.WangQ
GLP-1 receptor agonists are prescribed to manage type 2 diabetes by regulating blood sugar and, in some cases, to support weight loss
Meghan McGee-Lawrence received the Notice of Award for an NIH S10 equipment grant, supporting the purchase of a ~$400K in vivo micro-computed tomography instrument that will be utilized by faculty and staff in CBA, DNRM, VBC, Medicine, and Oral Biology
The needs for diabetes management exceed what telehealth offers, encompassing blood glucose monitoring, A1C testing, and endocrinological coordination
Kiinin inslin direnci, kan ekeri dengesi, kilo ynetimi hedefi, hormonal durumu ve mevcut salk gemii birlikte deerlendirilmelidir
Introduction The widespread success of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro has transformed the landscape of metabolic health and weight management